| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide new methods and kits for diagnosing, treating and preventing cancer, specifically, methods and kits for avoiding the dangers related to tissue biopsy. <P>SOLUTION: The methods and kits are to diagnose tumorigenicity, by measuring the concentration of GP88 in blood, plasma, serum, saliva, urine and other biological fluids. The methods and kits are for detecting GP88 in biological fluids, at a concentration as low as about 0.1 to 10 nanograms per milliliter and are useful for determining whether a patient has a tumorigenic condition, whether the patient is likely to be responsive to anti-tumorigenic therapies, and whether the treated patient is responding to anti-tumorigenic therapy, by measuring the concentration of GP88 in the patient's serum or other biological fluid. <P>COPYRIGHT: (C)2009,JPO&INPIT</p> |
